Kulukurssi:
Can those of you who believe in the power of new CEOs and/or board members explain to a simple guy how the situation would change after a replacement?
I’ve always been of the opinion that it doesn’t matter who sits in the chair, as long as it’s not consumer retail where a leader-worshipping community rushes to shop on command when the need strikes.
I suppose they couldn’t change the direction anyway, because the product has approvals, obstacles have been removed, and obstacles will continue to be removed. Approvals are being sought for new products and obstacles are removed as they are identified.
Explain it in very simple terms.
It matters quite a lot what kind of strategy has been formulated and how it is implemented. Perhaps with a board change, the strategy would be a notch closer to optimal, or by changing the CEO, this strategy would be implemented more optimally.
I don’t know if Optomed’s strategy is the best possible one and if it is currently being implemented in the best possible way. So, I’m not here calling for changes.
However, the board’s share positions are a concern. I didn’t even remember that my own stack is still larger than that of any single board member. If I remember correctly, there have been times when I had more than the entire board combined.
Apparently, this position and company in my portfolio interest a small investor like me this much. Hopefully, the board is more interested.
I seem to remember looking at the management team’s option programs and they looked sensible. So I believe my interests are aligned with theirs. I’m not so sure about the board.